This control is formulated for use as an unassayed serum control with in vitro diagnostic test kits for the qualitative detection of IgM antibodies to Borrelia burgdorferi (Lyme Disease). ACCURUN 132 is manufactured from human serum or plasma, reactive for anti-Borrelia burgdorferi. For in vitro diagnostic use.
Tackling administrative challenges in healthcare enterprises often means big resource commitments that take years to pay off. But on-call scheduling technology can reverse that equation, delivering impressive ROI from a relatively modest investment of time and money.